Press / Medias

Health and Life Science deals

Sep 28, 2017

LNC Therapeutics, a French company specializing in the research and development of gut microbiota directed drugs for the treatment of obesity and associated cardiometabolic diseases, raised €6.5 million ($7.7 million) in Series C funding.

In the same category

Press / Medias

YSOPIA Bioscience : Restaurer le microbiome pour soigner !

Apr 14, 2022

more +
Press / Medias

Seventure Partners : Une croissance continue dans le secteur du microbiome en 2021 qui va se...

Mar 15, 2022

more +
Press / Medias

Inria partage son expertise avec la biotech bordelaise Ysopia

Feb 2, 2022

more +

YSOPIA Bioscience © 2022 - all rights reserved terms and conditions